Cargando…

Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients

CADASIL is a vascular protein aggregation disorder caused by cysteine-altering NOTCH3 variants, leading to mid-adult-onset stroke and dementia. Here, we report individuals with a cysteine-altering NOTCH3 variant that induces exon 9 skipping, mimicking therapeutic NOTCH3 cysteine correction. The inde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gravesteijn, Gido, Dauwerse, Johannes G, Overzier, Maurice, Brouwer, Gwendolyn, Hegeman, Ingrid, Mulder, Aat A, Baas, Frank, Kruit, Mark C, Terwindt, Gisela M, van Duinen, Sjoerd G, Jost, Carolina R, Aartsma-Rus, Annemieke, Lesnik Oberstein, Saskia A J, Rutten, Julie W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	General Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372551/ https://www.ncbi.nlm.nih.gov/pubmed/31960911 http://dx.doi.org/10.1093/hmg/ddz285

Ejemplares similares

Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL
por: Rutten, Julie W., et al.
Publicado: (2016)

NO TCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature
por: Gravesteijn, Gido, et al.
Publicado: (2021)

Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance
por: Rutten, Julie W., et al.
Publicado: (2020)

The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation
por: Rutten, Julie W., et al.
Publicado: (2015)

Progression and Classification of Granular Osmiophilic Material (GOM) Deposits in Functionally Characterized Human NOTCH3 Transgenic Mice
por: Gravesteijn, Gido, et al.
Publicado: (2019)

Effect of NOTCH3 EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes
por: Hack, Remco J., et al.
Publicado: (2022)

Serum Neurofilament light correlates with CADASIL disease severity and survival
por: Gravesteijn, Gido, et al.
Publicado: (2018)

Eighteen-Year Disease Progression and Survival in CADASIL
por: Gravesteijn, Gido, et al.
Publicado: (2021)

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic NOTCH3 Variant Can Have a Normal Brain Magnetic Resonance Imaging and Skin Biopsy Beyond Age 50 Years
por: Hack, Remco J., et al.
Publicado: (2022)

Commentary to: Masoli et al. Clinical Outcomes of CADASIL-Associated NOTCH3 mutations in 451,424 European Ancestry Community Volunteers. (Translational Stroke Research Oct 2018)
por: Rutten, J. W., et al.
Publicado: (2018)

Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction
por: Hack, Remco J, et al.
Publicado: (2022)

Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model
por: Oliveira, Daniel V, et al.
Publicado: (2022)

Cognition, mood and behavior in CADASIL
por: Chabriat, Hugues, et al.
Publicado: (2022)

No vessel wall abnormalities in a human foetus with a NOTCH3 mutation
por: Lesnik Oberstein, Saskia A. J., et al.
Publicado: (2008)

The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant
por: Rutten, Julie W., et al.
Publicado: (2018)

Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant
por: Rutten, Julie W., et al.
Publicado: (2018)

NOTCH3 Variants in Patients with Suspected CADASIL
por: Gorukmez, Orhan, et al.
Publicado: (2023)

Headache and NOTCH3 Gene Variants in Patients with CADASIL
por: Szymanowicz, Oliwia, et al.
Publicado: (2023)

Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
por: Aartsma-Rus, Annemieke
Publicado: (2022)

Broadening the Genetic Horizons of CADASIL: New Variants of the NOTCH3 Gene Revealed and their Association with CADASIL
por: Mishra, Biswamohan, et al.
Publicado: (2023)

Novel mutation of the notch3 gene in arabic family with CADASIL
por: Bohlega, Saeed
Publicado: (2011)

Biochemical Characterization and Cellular Effects of CADASIL Mutants of NOTCH3
por: Meng, He, et al.
Publicado: (2012)

NOTCH3 and CADASIL syndrome: a genetic and structural overview
por: Papakonstantinou, Eleni, et al.
Publicado: (2019)

Combined deficiency of Notch1 and Notch3 causes pericyte dysfunction, models CADASIL, and results in arteriovenous malformations
por: Kofler, Natalie M., et al.
Publicado: (2015)

Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients
por: Tikka, Saara, et al.
Publicado: (2009)

Identification of a Known Mutation in Notch 3 in Familiar CADASIL in China
por: Tan, Zhen-Xuan, et al.
Publicado: (2012)

Notch3 and its CADASIL mutants differentially regulate cellular phenotypes
por: Lin, Chunjing, et al.
Publicado: (2021)

NOTCH3 Variants and Genotype-Phenotype Features in Chinese CADASIL Patients
por: Hu, Yacen, et al.
Publicado: (2021)

A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL
por: Li, Juyi, et al.
Publicado: (2022)

In-Depth Characterization of Protein Disulfide Bonds by Online Liquid Chromatography-Electrochemistry-Mass Spectrometry
por: Switzar, Linda, et al.
Publicado: (2015)

The Effect of 6-Thioguanine on Alternative Splicing and Antisense-Mediated Exon Skipping Treatment for Duchenne Muscular Dystrophy
por: Verhaart, Ingrid E. C., et al.
Publicado: (2012)

Exon skipping for DMD
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2012)

Molecular Chaperone BRICHOS Inhibits CADASIL-Mutated NOTCH3 Aggregation In Vitro
por: Oliveira, Daniel V., et al.
Publicado: (2022)

Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations
por: Ni, Wang, et al.
Publicado: (2022)

Corrigendum: A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL
por: Li, Juyi, et al.
Publicado: (2023)

Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
por: Hack, Remco J., et al.
Publicado: (2020)

A Novel Cysteine-Sparing NOTCH3 Mutation in a Chinese Family with CADASIL
por: Ge, Wei, et al.
Publicado: (2014)

R54C Mutation of NOTCH3 Gene in the First Rungus Family with CADASIL
por: Lim, Kheng-Seang, et al.
Publicado: (2015)

Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL
por: Machuca-Parra, Arturo I., et al.
Publicado: (2017)

Detection of Vascular Notch3 Deposits in Unfixed Frozen Skin Biopsy Sample in CADASIL
por: Ueda, Akihiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fgf85j2e1smn24onqss17a69t4